3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
5
Completed
4
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
72
Lung Neoplasms
9
Adenocarcinoma of Lung
7
Brain Neoplasms
5
Non-squamous Non-small Cell Lung Cancer
4
NSCLC
4
Adenocarcinoma
4
Mesothelioma, Malignant
3
Colorectal Neoplasms
3
Nonsquamous Non-Small Cell Lung Cancer
2
Non-squamous Cell Non-Small Cell Lung Cancer
2
Neoplasms
2
Meningeal Carcinomatosis
2
Lymphoma
2
Glioma
2
Central Nervous System Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Untreated Advanced Non-Small Cell Lung Cancer
1
Unresectable Stage III NSCLC
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Staging IV NSCLC
1
Squamous Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Interventions
Cyclophosphamide
17
fludarabine
13
Dexamethasone
12
Cisplatin
11
Rituximab
10
Gemcitabine
9
Paclitaxel
7
Lenalidomide
7
Decitabine
7
Cytarabine
7
Bendamustine Hydrochloride
7
fludarabine phosphate
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
6
Etoposide
6
Carboplatin
6
Bortezomib
6
Radiotherapy
5
Injections
5
Azacitidine
5
camrelizumab
4
apatinib
4
Valproic Acid
4
Thalidomide
4
Procarbazine
4
Oxaliplatin
4
Drug Therapy
4
Antilymphocyte Serum
4
tislelizumab
3
pomalidomide
3
liposomal doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Recurrence
×
Pemetrexed
×
Clear all
NCT00786552
2011-01-20
Panthera
University Hospital Schleswig-Holstein
Phase 2
Unknown
47 enrolled